Shire logo

SHP - Shire News Story

4690p 0.0  0.0%

Last Trade - 04/01/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £12.32bn
Position in Universe th / 1807

EXCLUSIVE-EU regulators to clear $62 bln Takeda, Shire deal - source

Fri 9th November, 2018 4:25pm
BRUSSELS, Nov 9 (Reuters) - EU antitrust regulators are set
to approve Japanese drugmaker Takeda Pharmaceutical's  4502.T 
$62-billion offer for London peer Shire on condition that Shire
sells a drug it has in development, a person familiar with the
matter said on Friday.
    Last month, Takeda offered to divest Shire's pipeline
compound SHP647 along with some associated rights after the
European Commission voiced concerns about the overlap with its
own drug for inflammatory bowel disease.

 (Reporting by Foo Yun Chee)
 ((foo.yunchee@thomsonreuters.com; +32 2 287 6844; Reuters
Messaging: foo.yunchee.thomsonreuters.com@reuters.net))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.